Alopecia Market Report 2026

Alopecia Market Overview

• Alopecia market size has reached to $11.48 billion in 2025 • Expected to grow to $14.29 billion in 2030 at a compound annual growth rate (CAGR) of 4.6% • Growth Driver: Rising Prevalence Of Hair Loss Driving Growth In The Alopecia Market • Market Trend: New Oral JAK Therapy Strengthens Treatment Options For Severe Alopecia • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Alopecia Market?

Alopecia is a medical term that refers to hair loss, which can occur naturally or be related to disease or the use of certain medications. It can be localized or diffuse, temporary or permanent, and can affect both sexes and all age groups. Alopecia treatment aims to slow down, reverse, or manage hair loss and promote hair regrowth in affected areas. The main types of alopecia are alopecia areata androgenetic alopecia, alopecia totalis, traction alopecia, cicatricial alopecia and others. Alopecia areata is an autoimmune condition characterized by sudden hair loss that results in round or oval patches on the scalp or other body areas. The various treatments include pharmaceuticals, low-level laser therapy devices, hair transplants, regenerative medicine, and others. The multiple genders have males and females. These are distributed through various distribution channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and others, and are used by multiple end-users, such as dermatology clinics, home care settings, and others.

What Is The Alopecia Market Growth Forecast?

The alopecia market size is expected to see steady growth in the next few years. It will grow to $14.29 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to development of novel regenerative medicine therapies, technological advancements in lltt devices, growing adoption of personalized alopecia treatments, expansion of online pharmacy distribution channels, increasing investment in hair restoration research. Major trends in the forecast period include increasing adoption of pharmaceutical treatments for hair loss, rising use of low-level laser therapy (lllt) devices, growth in hair transplant procedures, expansion of regenerative medicine applications for alopecia, increasing awareness and access to homecare hair loss treatments.

What Is The Driver Of The Alopecia Market?

The increase in the prevalence of hair loss is expected to propel the growth of the alopecia market going forward. Hair loss refers to the partial or complete loss of hair from areas where it usually grows. Alopecia treatment helps alopecia patients by addressing several issues with hair loss by extending hair regrowth, creating customized treatment plans, using combination therapies, and managing the physical aspect of hair loss, as these can have significant positive effects on a person's emotional well-being and quality of life. For instance, in April 2023, according to the data from the National Health Commission, a China-based executive department, over 250 million Chinese experienced hair loss, of which 42% were aged between 26 and 30. Furthermore, in February 2023, according to the Statistic Brain Research Institute, a US-based educational institute, approximately 40% of men will suffer from visible hair loss by age 35. Therefore, the increase in the prevalence of hair loss is driving the alopecia industry.

Key Players In The Global Alopecia Market

Major companies operating in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan Plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company Plc, Dr. Reddy's Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.

Global Alopecia Market Trends and Insights

Major companies operating in the alopecia market are focusing on developing innovative products such as oral JAK inhibitors to enhance treatment effectiveness and deliver faster, more durable hair regrowth for patients with autoimmune hair loss. An oral JAK inhibitor is a targeted pharmacologic agent that modulates immune-mediated inflammation by blocking Janus kinase pathways involved in follicular attack. For instance, in July 2025, Sun Pharmaceutical Industries Limited, an India-based specialty generics and dermatology-focused pharmaceutical company, launched LEQSELVI (deuruxolitinib) in the United States. The therapy demonstrated rapid clinical improvement, with a significant proportion of patients achieving meaningful scalp hair regrowth as early as eight weeks. Its introduction offers a timely, evidence-backed treatment option for severe alopecia areata, expanding therapeutic choices for both clinicians and patients.

What Are Latest Mergers And Acquisitions In The Alopecia Market?

In March 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. With this acquisition, Sun Pharmaceutical aims to improve and enhance its alopecia treatment offerings and expand its product portfolio. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company involved in developing oral inhibitors of Janus kinases as a treatment for alopecia areata.

What Defines the Alopecia Market?

The alopecia market consists of revenues earned by entities by providing anagen effluvium, telogen effluvium, and alopecia universalis treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia market also includes the sales of shampoos, drugs, and hair regrowth supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Alopecia Market Report 2026?

The alopecia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the alopecia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.